🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523737-26-00
Authorised Phase I

A Pilot, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Tolerability, Safety, and Pharmacokinetics of a Single Intra-articular Injection of CNTX-0066 in Participants with Chronic, Moderate-to-Severe Osteoarthritis Knee Pain

2025-523737-26-00 · tracked via the Priya Life Science EU tracker
Sponsor
Centrexion Therapeutics Corp.
Sponsor type
Pharmaceutical company
Therapeutic area
Musculoskeletal Diseases
Decision date
24/02/2026
Enrollment target
20
Sites
Denmark

Condition studied

Osteoarthritis of the knee

Eligibility

Age group
65+ years, 18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523737-26-00 on CTIS ↗ ← All trials in the EU